Genetic Analysis of the Plant Defense Response

植物防御反应的遗传分析

基本信息

  • 批准号:
    7895275
  • 负责人:
  • 金额:
    $ 22.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-18 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Plants and animals respond to PAMPs (pathogen-associated molecular patterns) that are indicative of pathogens. Oligogalacturonides (OGs), plant cell wall fragments generated by pathogen polygalacturonases, function as a PAMP in Arabidopsis thaliana. We hypothesize that OG-activated innate immune response pathways are among the most ancient and are most similar to so-called "Toll-like" innate immune signaling pathways in animals. An important unanswered question in plant innate immunity is how PAMP-activated pathways relate to signaling pathways that respond to pathogen-specific signals. The specific aims are designed to further investigate Arabidopsis OG signaling pathway(s) and to identify Pseudomonas syringae Type III effectors that disrupt these pathways. We also hypothesize those Og-activated genes that encode cytochrome P450s function in the biosynthesis of antimicrobial compounds. We have found that some P. syringae strains elicit the exudation of antimicrobial secondary products from Arabidopsis roots, but that P. syringae strain DC3000 blocks this exudation in a process that involves Type III secretion. This is a novel system to study how PAMP-elicited innate immune responses confer basal resistance and how pathogens overcome this resistance. There are five aims. We propose to use a variety of molecular genetic and genomic methods to determine how the OG signaling pathway intersects with other defense response signaling pathways. We will use forward genetic and genomic analyses to identify components of OG signaling pathway(s). We will identify P. syringae type III effectors that block OG-activated signaling pathways and/or the synthesis/exudation of antimicrobial compounds by roots. We will identify signaling pathways that lead to the biosynthesis of antimicrobial compounds. Finally, we will enter the data from this project into IMDS, a public, web-accessible relational database.
描述(由申请人提供):植物和动物对指示病原体的 PAMP(病原体相关分子模式)做出反应。寡聚半乳糖醛酸 (OG) 是由病原体多聚半乳糖醛酸酶产生的植物细胞壁片段,在拟南芥中充当 PAMP。我们假设 OG 激活的先天免疫反应途径是最古老的,并且与动物中所谓的“Toll 样”先天免疫信号传导途径最相似。植物先天免疫中一个重要的未解答问题是 PAMP 激活途径如何与响应病原体特异性信号的信号途径相关。具体目标是进一步研究拟南芥 OG 信号通路并鉴定破坏这些通路的丁香假单胞菌 III 型效应子。我们还假设那些编码细胞色素 P450 的 Og 激活基因在抗菌化合物的生物合成中发挥作用。我们发现,一些丁香假单胞菌菌株引起拟南芥根部分泌抗菌次级产物,但丁香假单胞菌菌株 DC3000 在涉及 III 型分泌的过程中阻止了这种分泌。这是一个新的系统,用于研究 PAMP 引发的先天免疫反应如何赋予基础抵抗力以及病原体如何克服这种抵抗力。有五个目标。我们建议使用多种分子遗传学和基因组方法来确定 OG 信号通路如何与其他防御反应信号通路交叉。我们将使用正向遗传和基因组分析来识别 OG 信号通路的组成部分。我们将鉴定出丁香假单胞菌 III 型效应子,其阻断 OG 激活的信号通路和/或根部抗菌化合物的合成/渗出。我们将确定导致抗菌化合物生物合成的信号通路。最后,我们将该项目的数据输入 IMDS,这是一个可通过网络访问的公共关系数据库。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Frederick M Ausubel其他文献

Frederick M Ausubel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Frederick M Ausubel', 18)}}的其他基金

First-in-class small molecule therapeutics to enhance gut barrier function in inflammatory bowel disease
一流的小分子疗法可增强炎症性肠病的肠道屏障功能
  • 批准号:
    10251430
  • 财政年份:
    2021
  • 资助金额:
    $ 22.87万
  • 项目类别:
First-in-class small molecules that enhance lung barrier function during acute respiratory distress syndrome (ARDS) as potential therapeutics for COVID-19
一流的小分子,可增强急性呼吸窘迫综合征 (ARDS) 期间的肺屏障功能,作为 COVID-19 的潜在疗法
  • 批准号:
    10254996
  • 财政年份:
    2021
  • 资助金额:
    $ 22.87万
  • 项目类别:
Discovering Novel Therapeutics for Myotonic Dystrophy Type 1 (DM1)
发现 1 型强直性肌营养不良 (DM1) 的新疗法
  • 批准号:
    9409067
  • 财政年份:
    2017
  • 资助金额:
    $ 22.87万
  • 项目类别:
Identifying novel anti-infectives by high through-put screening in whole animals
通过对整体动物进行高通量筛选来鉴定新型抗感染药物
  • 批准号:
    7764005
  • 财政年份:
    2009
  • 资助金额:
    $ 22.87万
  • 项目类别:
Harvard-wide Program on Antibiotic Resistance
哈佛大学抗生素耐药性计划
  • 批准号:
    8531132
  • 财政年份:
    2009
  • 资助金额:
    $ 22.87万
  • 项目类别:
Identifying novel anti-infectives by high through-put screening in whole animals
通过对整体动物进行高通量筛选来鉴定新型抗感染药物
  • 批准号:
    8312372
  • 财政年份:
    2009
  • 资助金额:
    $ 22.87万
  • 项目类别:
Identifying novel anti-infectives by high through-put screening in whole animals
通过对整体动物进行高通量筛选来鉴定新型抗感染药物
  • 批准号:
    8126254
  • 财政年份:
    2009
  • 资助金额:
    $ 22.87万
  • 项目类别:
Harvard-wide Program on Antibiotic Resistance
哈佛大学抗生素耐药性计划
  • 批准号:
    8716642
  • 财政年份:
    2009
  • 资助金额:
    $ 22.87万
  • 项目类别:
Identifying novel anti-infectives by high through-put screening in whole animals
通过对整体动物进行高通量筛选来鉴定新型抗感染药物
  • 批准号:
    7939581
  • 财政年份:
    2009
  • 资助金额:
    $ 22.87万
  • 项目类别:
Identifying novel anti-infectives by high through-put screening in whole animals
通过对整体动物进行高通量筛选来鉴定新型抗感染药物
  • 批准号:
    8520165
  • 财政年份:
    2009
  • 资助金额:
    $ 22.87万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
    Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 22.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了